ASTRAZENECA PHARMA INDIA
|
ASTRAZENECA PHARMA INDIA Last 5 Year Cashflow Statement History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit Before Tax | ₹220 Cr | ₹134 Cr | ₹83 Cr | ₹127 Cr | ₹114 Cr |
Adjustment | ₹-7.07 Cr | ₹-4.80 Cr | ₹9.66 Cr | ₹14 Cr | ₹9.75 Cr |
Changes In working Capital | ₹-128 Cr | ₹-30 Cr | ₹33 Cr | ₹-3.95 Cr | ₹-2.66 Cr |
Cash Flow after changes in Working Capital | ₹84 Cr | ₹99 Cr | ₹126 Cr | ₹137 Cr | ₹121 Cr |
Cash Flow from Operating Activities | ₹28 Cr | ₹58 Cr | ₹101 Cr | ₹105 Cr | ₹87 Cr |
Cash Flow from Investing Activities | ₹22 Cr | ₹18 Cr | ₹4.74 Cr | ₹173 Cr | ₹-171 Cr |
Cash Flow from Financing Activities | ₹-44 Cr | ₹-24 Cr | ₹-9.46 Cr | ₹-8.97 Cr | ₹-6.36 Cr |
Net Cash Inflow / Outflow | ₹5.23 Cr | ₹52 Cr | ₹96 Cr | ₹269 Cr | ₹-90 Cr |
Opening Cash & Cash Equivalents | ₹500 Cr | ₹448 Cr | ₹352 Cr | ₹84 Cr | ₹173 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
Closing Cash & Cash Equivalent | ₹506 Cr | ₹500 Cr | ₹448 Cr | ₹352 Cr | ₹84 Cr |
Compare Cashflow Statement of peers of ASTRAZENECA PHARMA INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ASTRAZENECA PHARMA INDIA | ₹17,784.4 Cr | -2.9% | 6.8% | 27.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹443,661.0 Cr | -1.8% | 2.7% | 49.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,496.0 Cr | -0.2% | -3.4% | 57% | Stock Analytics | |
CIPLA | ₹121,970.0 Cr | -0.7% | 0.6% | 22.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,877.0 Cr | -1.8% | 11.3% | 18% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,163.2 Cr | 1.9% | 0.5% | 41.9% | Stock Analytics |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ASTRAZENECA PHARMA INDIA | -2.9% |
6.8% |
27.1% |
SENSEX | 0.7% |
-2% |
9.7% |
You may also like the below Video Courses